We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Amneal Pharmaceuticals Inc
20 own
29 watching
Current Price
$7.85
$0.06
(0.77%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,093.8M
52-Week High
9.47500
52-Week Low
5.010000
Average Volume
0.35M
Dividend Yield
--
P/E Ratio
84.6746
Market Capitalization1,093.8M52-Week High9.4750052-Week Low5.010000Average Volume0.35MDividend Yield--P/E Ratio84.6746What does the Amneal Pharmaceuticals Inc do?
Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").
Read More
How much money does Amneal Pharmaceuticals Inc make?
News & Events about Amneal Pharmaceuticals Inc.
TipRanks Financial Blog
1 year ago
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group ... Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group...
PR Newswire
1 year ago
Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? PR Newswire NEW YORK, July...
Business Wire
1 year ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced the launch of its authorized generic for Xyrem1 (Sodium Oxybate) oral solution CIII in the United States. Sodium Oxybate oral solution, 0.5 g/mL is a central nervous system depressant indicated for the treatment of...
Business Wire
1 year ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Companys New Drug Application (NDA) for IPX203 for the treatment of Parkinsons disease. The letter...
Tickeron - Stocks
1 year ago
This is a signal that AMRX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Frequently Asked Questions
Frequently Asked Questions
What is Amneal Pharmaceuticals Inc share price today?
Can Indians buy Amneal Pharmaceuticals Inc shares?
How can I buy Amneal Pharmaceuticals Inc shares from India?
Can Fractional shares of Amneal Pharmaceuticals Inc be purchased?
What are the documents required to start investing in Amneal Pharmaceuticals Inc stocks?
What is today’s traded volume of Amneal Pharmaceuticals Inc?
What is today’s market capitalisation of Amneal Pharmaceuticals Inc?
What is the 52-Week High and Low Range of Amneal Pharmaceuticals Inc?
What percentage is Amneal Pharmaceuticals Inc down from its 52-Week High?
What percentage is Amneal Pharmaceuticals Inc up from its 52-Week Low?
Current Price
$7.85
$0.06
(0.77%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.